Physician profile
Nathaniel W Lytle
NPI 1205031895
$117,643.02
in general payments reported to CMS, 2019-2025
31 companies · $50K in 2025
The $50K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,801 · 2020: $1,822 · 2021: $16K · 2022: $16K · 2023: $18K · 2024: $12K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Education: $24K · Travel and Lodging: $9,016 · Food and Beverage: $5,386 · Consulting Fee: $4,550 · Honoraria: $500 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,800.00 |
| Education | $24,000.00 |
| Travel and Lodging | $9,015.71 |
| Food and Beverage | $5,386.04 |
| Consulting Fee | $4,550.00 |
| Honoraria | $500.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $58,266.60 | 2019-2025 | Da Vinci Surgical System |
| Teleflex LLC | $46,947.60 | 2019-2025 | Titan Sgs Bailout Chuck, Titan Sgs, Titan Sgs Standard Gastric Stapler |
| Ambu INC. | $2,434.28 | 2020-2024 | |
| Medtronic, INC. | $2,332.19 | 2021-2025 | Endoflip, Bravo, Appose Ulc |
| W. L. Gore & Associates, INC. | $1,535.61 | 2019-2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Baxter Healthcare | $1,334.11 | 2019-2024 | Tisseel, Peri-Strips Dry |
| Intra-Sana Laboratories | $1,320.29 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ambu A/S | $1,000.00 | 2024 | |
| Asensus Surgical, INC. | $810.00 | 2019 | |
| Covidien LP | $394.23 | 2019-2020 | |
| Ethicon US, LLC | $220.12 | 2022-2024 | Enseal, Echelon Endopath, Linx Reflux Management System |
| Innovation Technologies INC | $173.26 | 2019-2025 | Irrisept |
| Tela Bio, INC. | $167.61 | 2022 | |
| Allergan, INC. | $148.36 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $89.38 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kvk-Tech, INC. | $81.05 | 2025 | |
| Companion Medical, INC. | $54.25 | 2019 | |
| Integra Lifesciences Corporation | $47.31 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Heron Therapeutics, INC. | $39.34 | 2023-2024 | Zynrelef |
| Vivus LLC | $38.62 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $25.25 | 2025 | |
| Dexcom, INC. | $23.88 | 2025 | Dexcom G6 Transmitter |
| Coloplast Corp | $23.30 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.54 | 2024 | Exparel, Iovera |
| Abbott Laboratories | $22.16 | 2024 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $18.46 | 2022 | |
| Lilly USA, LLC | $17.84 | 2024 | Zepbound |
| Novo Nordisk INC | $16.50 | 2023 | Wegovy |
| Davol INC. | $16.33 | 2019 | |
| Endo Pharmaceuticals INC. | $11.29 | 2021 | |
| Redhill Biopharma INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Lytle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.